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Abstract
The discovery in the late 1990s of the partnership between the RET receptor tyrosine kinase and the GFRα family of GPI-
anchored co-receptors as mediators of the effects of GDNF family ligands galvanized the field of neurotrophic factors, firmly
establishing a new molecular framework besides the ubiquitous neurotrophins. Soon after, however, it was realized that many
neurons and brain areas expressed GFRα receptors without expressing RET. These observations led to the formulation of two
new concepts in GDNF family signaling, namely, the non-cell-autonomous functions of GFRα molecules, so-called trans
signaling, as well as cell-autonomous functions mediated by signaling receptors distinct from RET, which became known as
RET-independent signaling. To date, the best studied RET-independent signaling pathway for GDNF family ligands involves the
neural cell adhesion molecule NCAM and its association with GFRα co-receptors. Among the many functions attributed to this
signaling system are neuronal migration, neurite outgrowth, dendrite branching, spine formation, and synaptogenesis. This
review summarizes our current understanding of this and other mechanisms of RET-independent signaling by GDNF family
ligands and GFRα receptors, as well as their physiological importance.
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Introduction
Although the concept of neurotrophic factors as target-derived
survival molecules originated from studies of the developing
nervous system, it quickly grabbed the attention of researchers
investigating neuronal death in neurodegenerative diseases, such
as Parkinson’s disease, and how to prevent it. The early 1990s
saw the expansion of the neurotrophin family, the paradigm of
neurotrophic factors, and a flurry of activity characterizing their
functions in different neuronal populations. However, the
neurotrophins were never very potent at promoting survival of
midbrain dopaminergic neurons, the main neuronal population
that degenerates in Parkinson’s disease, and the search was on at
multiple laboratories for what many scientists thought would be
“bonafide” survival factors for this class of neurons. This is how
glial cell line-derived neurotrophic factor (GDNF) was discov-
ered and first reported in 1993 (Lin et al. 1993). Structural sim-
ilarities between GDNF and members of the TGFβ superfamily
initially misdirected efforts to identify GDNF receptors. The
RET receptor tyrosine kinase was eventually identified as the
first functional receptor for GDNF, based on its biochemical
properties as well as the phenotypic similarities between RET
and GDNF knock-out mice (Durbec et al. 1996; Trupp et al.
1996). But RET could not bind GDNF on its own with high
affinity, and so expression-cloning studies based onGDNF bind-
ing led to the identification of the GPI (glycosyl-phosphatidyl-
inositol)-anchored co-receptor GFRα1 (named GDNFR-α at the
time) as a necessary component of the GDNF receptor complex
together with RET (Jing et al. 1996; Treanor et al. 1996). The
concept was attractive in its elegance and simplicity. RET could
not bind GDNF with high affinity, but it could signal through its
tyrosine kinase domain. Andwhile GFRα1 could bind GDNF, it
was not expected to signal due to its lack of an intracellular
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domain. This notion required strict co-expression of the two
receptors in the same cell for a functional complex to be assem-
bled, and, indeed, midbrain dopaminergic neurons do express
both RET and GFRα1 (Treanor et al. 1996). However, several
detailed expression studies that followed could show that many
other neurons in the brain as well as cells elsewhere did not
(Trupp et al. 1997; Yu et al. 1998). Although the subsequent
discovery of GFRα family members GFRα2, 3, and 4, all of
which associate with RET tomediate signaling by GDNF family
ligands NTN, ART, and PSP, respectively (reviewed in
Airaksinen and Saarma (2002), Airaksinen et al. (1999)) helped
to account for sites that expressed RET without GFRα1, it only
expanded the list of cell types that had GFRα receptors but not
RET. What was going on in those cells?
At the time, a small group of researchers adhered to the null
hypothesis, namely, that GFRα molecules were actually not
doing anything on cells that did not express RET, an argument
that echoed Stephen J. Gould’s famous spandrels in San
Marco’s Cathedral (Gould and Lewontin 1979). In fact, some
evidence was presented which could be said supported that
notion (Enomoto et al. 2004). Admittedly, a lot remained to be
discovered back then. Other researchers, however, held on to
the traditional aphorism that “absence of evidence is not evi-
dence of absence” and so rationalized the problem of GFRα
expression without RET along the only two logical, though
non-mutually exclusive, possibilities available, namely, cell-
autonomous and non-cell-autonomous functions. In the latter
scenario, GFRαmolecules were proposed to function in trans
by presenting GDNF ligands to RET receptors expressed on
other cells. In the former, GFRα receptors were envisioned to
function without RET cell autonomously, either mediating
signaling on their own or together with other co-receptors, a
concept which became known as RET-independent signaling.
In this review, we first discuss mechanisms of trans signaling
in brief form, as these mainly utilize RET and so do not for-
mally fall into RET-independent signaling. This is followed
by a presentation of the phenomenon of ligand-induced cell
adhesion-mediated GDNF and GFRα molecules indepen-
dently of RET. We then present a more extended description
of RET-independent pathways, expanding on NCAM-
mediated signaling as well as other evidence pointing to alter-
native co-receptors and mechanisms.
Signaling in trans by GFRα molecules
GPI-anchored molecules lack transmembrane and intracellu-
lar domains; they are attached to the outer leaflet of the plasma
membrane by a glycolipid link. They are constitutively shed
from the surface of cells through the action of cell surface
lipases. It has been shown that GFRα1 can be released from
expressing cells and accumulate in soluble form in the cell
supernatant (Ledda et al. 2002; Paratcha et al. 2001).
Soluble GFRα1 is bioactive in that it can bind GDNF and
stimulate the activation of RET in cells (Paratcha et al. 2001;
Treanor et al. 1996; Yu et al. 1998). Released GFRα1 has
been proposed to mediate trans signaling by capturing
GDNF and presenting it to RET receptors through at least
three mechanisms: in soluble form, attached to the extracellu-
lar matrix or from the membrane of adjacent cells (Paratcha
et al. 2001). Many GDNF-responsive neurons expressing
RET project to brain regions rich in GFRα1 expression, sug-
gesting that they may normally be exposed to GFRα1 mole-
cules in trans (Trupp et al. 1997; Yu et al. 1998). The glyco-
lipid moiety of GPI-anchored receptors has affinity for spe-
cialized regions of the plasma membrane known as lipid rafts
(Simons and Toomre 2000), and GFRα1 readily partitions
into these compartments (Paratcha et al. 2001; Tansey et al.
2000; Trupp et al. 1999). Elegant studies showed that GFRα1
can recruit RET to lipid rafts upon GDNF binding, allowing
RET to signal from this membrane compartment (Paratcha
et al. 2001; Tansey et al. 2000). Intriguingly, activated RET
can trigger different signaling pathways depending on wheth-
er it is inside or outside rafts. For example, activated RET was
shown to associate with and phosphorylate different adaptor
proteins depending on its raft location: SHC outside lipid rafts
and FRS2 inside rafts (Paratcha et al. 2001). Altering the lo-
cation of active receptors in different membrane compart-
ments regulates and diversifies intracellular signal transduc-
tion. As exogenous GFRα1 is not associated with lipid rafts, it
was initially thought that activation in trans would be unable
to direct RET to these membrane compartments (Tansey et al.
2000). But other studies could demonstrate that exogenous
GFRα1 did indeed function in trans to relocate RET to lipid
rafts, albeit with a slower kinetics (Paratcha et al. 2001).
Interestingly, recruitment of RET to lipid rafts in trans, but
not in cis, was found to depend upon its tyrosine kinase activ-
ity, as well as the phosphorylation of Tyr1062, the FRS2-
binding site in RET (Paratcha et al. 2001). The FRS2 adaptor
protein associates with lipid rafts through a saturated acyl
chain (Kouhara et al. 1997), suggesting that lipid raft recruit-
ment of RET in trans was regulated by an intracellular mech-
anism, probably through interaction with FRS2 (Paratcha
et al. 2001). These results represented the first evidence that
receptors can be compartmentalized at the plasma membrane
by both extracellular and intracellular mechanisms (Paratcha
and Ibáñez 2002). The in vivo physiological importance of
lipid raft signaling by GFRα1 was probed in a study using
transgenic mice expressing a Gfra1 cDNA construct carrying
a transmembrane domain in place of the GPI-anchored signal
sequence introduced into the Gfra1 locus by homologous re-
combination, thus disrupting the expression of the endoge-
nous gene (Tsui et al. 2015). This construct had been pro-
duced in an earlier study and shown not to translocate to lipid
rafts in a cell line model (Tansey et al. 2000). Although the
knock-in mice expressed the transmembrane GFRα1 at nor-
mal levels, homozygous mice showed several phenotypes that
Cell Tissue Res
are characteristic of null mice lacking GFRα1, including renal
agenesis and loss of enteric neurons (Tsui et al. 2015).
Surprisingly, a protein showing GFRα1 immunoreactivity
was detected from supernatants of cells cultured from the
knock-in mice, indicating that it could be shed similarly to
its wild-type counterpart. However, whether the shed protein
had any biological activity in transwas not tested in the study.
It also remained unclear from these studies whether the trans-
membrane construct could still be present in the lipid rafts of
the mouse neurons or glial cells, despite the earlier cell line
result, as this was not assessed in the study. In any case, this
work strongly suggests that lipid raft signaling by GFRα1 is
also relevant in vivo.
It was later shown that GFRα signaling in trans offered
different possibilities to enhance and localize RET activity in
neurons as well as other cells. Worley et al. demonstrated that
both GFRα1 and GFRα2 added exogenously to cultures of
enteric neurons potentiated responses to GDNF and NTN,
even in neurons that also expressed endogenous GFRα recep-
tors (Worley et al. 2000). Intriguingly, they found that the
specificity of the responses to exogenous GFRα molecules
correlated with the type of cognate GFRα receptors expressed
in cis. In another study, Ledda et al. investigated functions of
exogenous GFRα1 molecules presented in localized fashion
to growth cones and axons of sensory neurons by coating
beads with recombinant GFRα1 protein (Ledda et al. 2002).
Under those conditions, exogenous GFRα1 was found to po-
tentiate neurite outgrowth and act as a long-range directional
cue by creating positional information for RET-expressing
axons in the presence of uniform concentrations of GDNF
(Ledda et al. 2002). Immobilized GFRα1 was able to drive
and reorient axonal growth along sites of GFRα1 expression.
Mechanistically, exogenous GFRα1 enhanced and sustained
the activation of cyclin-dependent kinase 5 (Cdk5), a lipid raft
protein and well-known regulator of axonal growth and guid-
ance (Dhavan and Tsai 2001). GFRα1 was the first receptor
shown to act non-cell autonomously as a guidance cue for
neurons (Crone and Lee 2002).
More recent studies from the past few years have shown
that trans signaling by GFRα receptors continues to explain a
multitude of biological processes. Patel and colleagues
showed that, in the gut, lymphoid tissue initiator cells express-
ing RET responded to GDNF family ligands presented in
trans by GFRα receptors expressed by adjacent cells (Patel
et al. 2012). In contrast, RET could be activated in cis in
enteric neurons (Patel et al. 2012). The multifaceted RET re-
sponses were determined by distinct patterns of expression of
the genes encoding RET and its co-receptors. The authors
concluded that activation of RET in transwas being deployed
to control the initial phase of enteric lymphoid organ morpho-
genesis, indicating that the specificity of RET signaling can be
regulated by differential co-expression of RET and GFRα
receptors. In another study, He et al. showed that GFRα1
released by sensory nerves could enhance cancer cell perineu-
ral invasion through activation of RET signaling in trans (He
et al. 2014). The authors found that RET activation, MAPK
pathway activity, and cancer cell migration towards GDNF
were increased upon exposure to soluble GFRα1.
Intriguingly, human pancreatic ductal adenocarcinomas dem-
onstrated great variability in their expression of GFRα1, indi-
cating alternative sources of GFRα1 in perineural invasion by
these cancer cells (He et al. 2014). One last example reviewed
here is the recent work by Fleming and colleagues, showing
how rapidly adapting mechanoreceptors in dorsal root ganglia
utilize GFRα2 in cis and GFRα1 in trans to mediate RET
activation necessary for survival and central projection growth
(Fleming et al. 2015). They find that mice lacking RET show
central projection deficits which were phenocopies by
Gfra1;Gfra2 double knock-outs, but not by the single
knock-outs (Fleming et al. 2015). They demonstrated that
GFRα1 produced by neighboring ganglion neurons activates
RET in mechanoreceptors, suggesting that trans and cis RET
signaling could function in the same developmental process.
Together, these studies show that trans signaling is deployed
in a number of developmental as well as physiological and
pathophysiological processes to enhance and diversify RET
signaling.
RET-independent ligand-induced cell adhesion by
GDNF and GFRα receptors
The discovery that GDNF could trigger trans-homophilic bind-
ing between GFRα1 molecules and cell adhesion between
GFRα1-expressing cells, independently of RET, presented for
the first time the phenomenon of “ligand-induced cell adhesion,”
a previously unknown mechanism for regulated cell-cell interac-
tion that combines features of both diffusible and membrane-
bound signals (Ledda et al. 2007). Subsequently, examples of
ligand-induced cell adhesion were found in other systems, such
as the ability of cerebelins to mediate cell adhesion between cells
expressing glutamate receptors and Neurexins (Uemura et al.
2010) and Slit-mediated cell adhesion between cells that express
Robo and Neurexin (Blockus et al. 2019).
Conventional cell adhesion mechanisms involve interac-
tions that occur by default, triggered by the simple encounter
of cell adhesion molecules with their partners in either
homophilic or heterophilic interactions. In contrast, ligand-
induced cell adhesion is a mechanism for cell-cell interaction
regulated by a soluble extracellular cue. The requirement for a
soluble signal makes it very versatile and highly regulatable.
In addition, by stimulating contact between two different cells,
the ligand may also trigger interactions between other ligand-
receptor systems and thereby indirectly elicit signaling events
that could also contribute to development and physiology. The
mechanisms by which GDNF can induce adhesion between
cells expressing GFRα1 receptors are still unclear. It was
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initially suggested that GDNF could promote homophilic in-
teractions between GFRα1 molecules in different cells by
“trans-dimerization,” acting as a physical bridge between
them. However, other ligands known to induce receptor di-
merization, such as nerve growth factor, were shown to be
incapable of inducing adhesion between receptor-expressing
cells (Ledda et al. 2007). Another possibility is that GDNF
acts through an allosteric mechanism by inducing conforma-
tional changes in GFRα1 that expose determinants responsi-
ble for trans-homophilic binding. Intriguingly, our unpub-
lished results indicate that contacts induced by GDNF be-
tween GFRα1-expressing cells are dependent on extracellular
heparin and the ability of GDNF and GFRα1 to bind heparin-
like molecules, suggesting that heparin-like substances may
help to bridge GDNF/GFRα1 complexes across cells during
ligand-induced cell adhesion (Ibáñez et al., unpublished).
A key physiological function for RET-independent ligand-in-
duced cell adhesion by GDNF and GFRα receptors has been dem-
onstrated in synapse formation and maintenance (reviewed in
(Ledda 2007)). In the first publication by Ledda et al., it was shown
that beads coated with GFRα1 could induce localized presynaptic
differentiation in hippocampal neurons at the sites of contact with
axons, as visualized by clustering of vesicular proteins and neuro-
transmitter transporters and by activity-dependent vesicle recycling
(Ledda et al. 2007) (Fig. 1). This effect required the presence of
GDNF in the culture medium, and in fact, GFRα1-coated beads
adhered to the surface of hippocampal neurons only when GDNF
was added. GFRα1 was found enriched at pre- and postsynaptic
compartments in hippocampal neurons, and presynaptic differentia-
tion induced by GDNF was markedly reduced in neurons lacking
GFRα1. Mice that were heterozygous for a null mutation in the
Gdnf gene showed reduced synaptic localization of presynaptic pro-
teins and a marked decrease in the density of presynaptic puncta
(Ledda et al. 2007). In agreementwith the importance ofGDNFand
GFRα1 for synaptogenesis in themouse hippocampus, a later study
used conditionalGfra1 knock-out mice lacking the receptor in sub-
populations of forebrain neurons and astrocytes and found that
GFRα1 is required for proper hippocampal dendritic arborization
and spine formation in vivo (Irala et al. 2016) (Fig. 1). Hippocampal
neurons lacking GFRα1 affected postsynaptic assembly, indicating
that GFRα1 is a bidirectional synaptic organizing protein. These
researchers found that signalingby theneural cell adhesionmolecule
NCAM was required for induction of dendrite growth and spine
formation by GDNF/GFRα1 in their system (Irala et al. 2016). In
the following section, we expand on the activities and physiological
function of NCAM as an alternative, RET-independent, signaling
receptor for GDNF ligands.
RET-independent signaling by GDNF and GFRα1
through the neural cell adhesion molecule NCAM
The search for GDNF receptors was motivated by the expec-
tation that these could be targeted with small molecules which
may someday become new therapies for Parkinson’s disease.
Researchers were looking for sources of such receptors in
primary cells and cell lines that showed binding activity and/
or biological responses to GDNF. RET and GFRα1 were
indeed discovered as a result of studies in kidney cells
(Durbec et al. 1996), motoneuron cell lines (Trupp et al.
1996), retinal ganglion cells (Jing et al. 1996), and midbrain
dopaminergic neurons (Treanor et al. 1996). After the storm
caused by the RET and GFRα1 discoveries settled down,
researchers were left with several cellular sources of GDNF-
binding activity that could not be explained by either of the
two receptors. Thus, for example, the neural precursor cell line
RN33B as well as primary Schwann cells expressed GFRα1
but not RET and displayed high molecular weight species in
chemical cross-linking experiments of ≈ 160 kDa (corre-
sponding to a GDNF-binding moiety of ≈ 140 kDa) that were
too small to be RET and too large to be dimers of GFRα1
(Paratcha et al. 2003; Trupp et al. 1999). In RN33B cells, a
Src-like kinase activity was recovered from lipid rafts and
GFRα1 immunoprecipitates that could be enhanced by stim-
ulation with GDNF (Trupp et al. 1999). This activity could
subsequently be attributed to Fyn kinase in both RN33B cells
and Schwann cells, leading to activation of the CREB tran-
scription factor (Paratcha et al. 2003; Trupp et al. 1999).
Based on its molecular weight, downstream signaling and
the type of cells where it could be found, one of us (G.P.)
speculated that the mysterious p140 could be the 140 kDa
isoform of the neural cell adhesion molecule NCAM. This
was subsequently confirmed by immunoprecipitation of
cross-linked complexes between GDNF and p140 with
NCAM antibodies, as well as reconstitution of GDNF binding
by transfection with NCAM cDNA in heterologous cells
(Paratcha et al. 2003). These studies also established that al-
though NCAM could associate with GDNF in the absence of
GFRα1, both receptors were required to generate high-
affinity-binding sites (KD ≈ 1 nM) and elicit downstream sig-
naling. Interestingly, other members of the GFRα (e.g.,
GFRα2 and 4) family could also mediate binding of their
corresponding ligands (i.e., NTN and PSP) to NCAM
(Paratcha et al. 2003). In addition to promoting high-affinity
binding of GDNF ligands, the association of GFRα1 with
NCAM prevented homophilic NCAM-NCAM interactions
(Paratcha et al. 2003), illustrating the ability of GFRα1 to
transform NCAM from a short-range cell adhesion molecule
into a long-range signaling receptor for diffusible GDNF li-
gands. Subsequent structure/function studies identified the
third immunoglobulin (Ig) domain of NCAM as the necessary
and sufficient determinant for its interaction with GDNF
(Nielsen et al. 2009; Sjöstrand et al. 2007) and established that
GFRα1 blocks NCAM-mediated cell adhesion through its
association with NCAM’s fourth Ig domain (Sjöstrand and
Ibáñez 2008). To date, a myriad of in vitro and in vivo studies
have provided a broad insight into the mechanisms through
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which RET-independent GDNF signaling through GFRα1
and NCAM regulates different cellular processes during ner-
vous system function and development. Functions attributed
to this alternative GDNF signaling system include prolifera-
tion (Bonafina et al. 2018), survival (Chao et al. 2003; Ilieva
et al. 2019), migration (Paratcha et al. 2003, 2006; Wan and
Too 2010), neurite outgrowth (Cao et al. 2008a; Chao et al.
2003; Irala et al. 2016; Nielsen et al. 2009; Paratcha et al.
2003), axon guidance (Charoy et al. 2012), and dendrite de-
velopment and synapse formation (Irala et al. 2016; Ledda
et al. 2007).
Early investigations using tissue explants from Ret- and
Ncam-null mice pointed to the importance of GDNF signaling
through GFRα1 and NCAM for migration of Schwann cells
as well as neuroblasts in the rostral migratory stream, both of
which express GFRα1 but not RET. GDNF-mediated
chemoattraction of Schwann cells and olfactory neuron pre-
cursors could be abolished by NCAM-blocking antibodies or
a null mutation in theNcam locus (Paratcha et al. 2006; 2003).
Moreover, Gfra1 knock-out mice phenocopied abnormalities
observed in the rostral migratory stream of Ncam knock-out
mice (Paratcha et al. 2003). Later studies found that the effects
of GFRα1 are restricted to precursor cells that give rise to all
major classes of OB interneurons, as the receptor is later
downregulated as these neurons mature (Zechel et al. 2018).
Conditional ablation of GFRα1 in embryonic GABAergic
cells recapitulated the cell losses previously observed in glob-
al Gfra1 knock-outs at birth (Marks et al. 2012), revealing a
requirement for the sustained generation and allocation of ol-
factory bulb interneurons. Conditional loss of GFRα1 in
GABAergic precursors altered the migratory behavior of
neuroblasts along the rostral migratory stream and affected
their differentiation (Zechel et al. 2018), phenotypes that are
all identical to those found in Ncam mutants (Chazal et al.
2000; Röckle and Hildebrandt 2016). Similarly, GDNF-
induced Schwann cell migration was also shown to require
Fig. 1 Schematic representation of the functional and structural plasticity
promoted by GDNF/GFRα1 in hippocampal neurons. The upper panel
(a) describes the morphological plastic changes reported in vivo in pyra-
midal (green) and adult-born dentate gyrus (DG) granule cells (GCs)
(blue) from wild-type (GFRα1-wt) and conditional GFRα1 knock-out
(cGFRα1-KO) mice. The lower panel (b) describes the axonal and
dendritic effects induced by GDNF reported in hippocampal primary
cultures in which GFRα1 expression was downregulated by knock-out
(GFRα1-KO) or knock-down (shGFRα1). The inserts display examples
of axonal terminals containing presynaptic vesicles and dendritic shafts
showing an array of mushroom (mature) and thin/stubby (immature) den-
dritic spines. Axons are represented in yellow
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binding to NCAM and activation of Fyn kinase (Paratcha et al.
2003; Zhou et al. 2003). In agreement with these findings,
subsequent studies established that RET-independent GDNF
signaling regulates Schwann cell function at pre-myelinated
stages by activating the NCAM-Fyn-ERK1/2-CREB signal-
ing pathway (Iwase, et al. 2005). Later studies used knock-
down of GDNF receptors to provide additional evidence
linking GDNF/NCAM signaling to migration of C6 glioma
cells (Wan and Too 2010). It could also be shown that ablation
of polysialic acid (PSA) chains from NCAM by enzymatic
treatment interferred with GDNF-induced migration of
TE671 skeletal muscle-derived cells (Conchonaud et al.
2007). In all these cases were the effects of GDNF on cell
migration mediated byNCAM in a RET-independent manner.
A recent study demonstrated that GDNF signaling through
GFRα1 antagonizes the effects of the mitogenic factor FGF2
in the proliferation and self-renewal of glutamatergic neural pro-
genitor cells at embryonic stages of cortical development.
Interestingly, these cortical progenitor cells lacked RET, and
the inhibitory effects of GDNF were antagonized by function-
blocking NCAM antibodies, supporting the role of GDNF/
GFRα1 signaling via NCAMs in cortical neurogenesis
(Bonafina et al. 2018). This finding is in line with previous work
indicating that NCAM overexpression reduced fibroblast cell
proliferation in response to FGF (Francavilla et al. 2007).
RET-independent GDNF signaling through GFRα1 and
NCAM has been shown to have diverse effects on axonal
growth and guidance in a variety of neuronal populations,
including hippocampal, cortical, and dopaminergic neurons
(Chao et al. 2003; Nielsen et al. 2009; Paratcha et al. 2003).
By investigating GDNF expression in gdnf-lacZ reporter
mice, Charoy and colleagues discovered a role for GDNF
signaling through NCAM in the guidance of commissural
axons of the spinal cord (Charoy et al. 2012). They found a
prominent and restricted expression of GDNF in the floor
plate, where commissural axons cross the midline.
Intriguingly, however, GDNF did not function as a direct
chemoattractant but instead enhanced responsiveness to the
midline repellent Semaphorin3B (Sema3B) by blocking
calpain1-mediated processing of the Sema3B signaling co-
receptor Plexin-A1 on crossing axons (Charoy et al. 2012).
Through genetic and in vitro experiments, this effect was
found to be mediated by GFRα1 and NCAM independently
of RET.
GDNF has been shown to have profound effects on synap-
se formation through GFRα1 and NCAM receptors indepen-
dently of RET. This was first shown in hippocampal neurons,
through the process of ligand-induced cell adhesion men-
tioned above. The effects on presynaptic maturation were ab-
rogated in GFRα1 knock-out-mice and partially inhibited in
animals deficient in NCAM, indicating that NCAM is a nec-
essary component for presynaptic machinery assembly in-
duced by GDNF (Ledda et al. 2007). On the postsynaptic side,
it was later found that postsynaptic differentiation induced by
GDNF could be abolished by knock-down of NCAM expres-
sion. This also abolished the ability of GDNF and GFRα1 to
induce growth and complexity of dendritic arbors and spines
in the postsynaptic neuron (Irala et al. 2016). More recently, it
was shown that GDNF signaling through GFRα1 is also re-
quired for proper dendritic maturation and synaptic integration
of adult-born granule hippocampal neurons in the dentate gy-
rus, as well as for correct spatial pattern separation memory in
mice (Bonafina et al. 2019) (Fig. 1). Adult-born hippocampal
granule cells express GFRα1 and NCAM but not RET, sug-
gesting a RET-independent mechanism with NCAM as the
main signaling receptor, although this remains to be formally
proven. Together, these studies reinforced the importance of
GDNF/GFRα1 signaling via NCAM for the establishment of
hippocampal connectivity. Additional studies will be required
to elucidate the contribution of the structural plasticity pro-
moted by GDNF, GFRα1, and NCAM in hippocampal neu-
rons to learning and memory processes.
Several studies have also investigated possible contribu-
tions of GDNF and NCAM signaling in different pathophys-
iological conditions, such as chronic pain, drug addiction,
neurodegeneration, and epilepsy. GDNF signaling through
NCAM was found to promote analgesia in a rat model of
neuropathic pain by modulating nociceptive responses in pe-
ripheral neurons (Sakai et al. 2008a, b). In cultured dopami-
nergic neurons of the ventral tegmental area, GDNF induced
activation of the NCAM-associated kinase FAK (focal adhe-
sion kinase), leading to reduced morphological and functional
neuroadaptative responses to chronic morphine (Li et al.
2014). Using the SH-SY5Y cell line, the same research group
later found that the neuroprotective effects of GDNF on chem-
ically induced neurotoxicity triggered by administration of
6OH-dopamine required NCAM translocation into lipid rafts
(Li et al. 2017). These findings were in agreement with an
early study indicating that the effects of GDNF on survival,
outgrowth, and dopamine turnover of midbrain dopaminergic
neurons could be antagonized by application of function-
blocking antibodies against NCAM (Chao et al. 2003), as well
as other studies highlighting the importance of NCAM for
survival of dopaminergic neurons in cell culture (Ditlevsen
et al. 2007) and dopaminergic neuron function in vivo (Xiao
et al. 2009). Additional evidence also suggests that GDNF
signaling via PSA-NCAM restricts seizure-induced hippo-
campal neurodegeneration and epileptogenesis through a
mechanism involving FAK phosphorylation (Duveau and
Fritschy 2010). Given the multiple roles of GDNF signaling
through NCAMon structural plasticity of a variety of neurons,
it is likely that many more pathophysiological processes will
be found in which this signaling system is implicated.
The ability of GFRα1 to inhibit NCAM-mediated cell ad-
hesion in a dose-dependent manner when either co-expressed
with NCAM in the same cell or exogenously added as a
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soluble protein suggested the possibility that GFRα1 and
NCAM could regulate nervous system development indepen-
dently of the presence of GDNF (Paratcha et al. 2003). The
first demonstration of the physiological importance of this
effect in vivo was presented by a recent study showing that
GFRα1 can function independently of GDNF and RET to
control Purkinje cell migration in the developing cerebellum
by counteracting NCAM function through direct binding
(Sergaki and Ibáñez 2017). In the absence of GFRα1,
Purkinje cell migration was delayed, but this effect could be
alleviated by reducing genetically NCAM expression. GFRα1
interacted directly with NCAM in Purkinje cells of the devel-
oping cerebellum (Sergaki and Ibáñez 2017). It is possible that
some of the effects observed in the rostral migratory stream of
Gfra1 null mutants, including abnormal migration and stream
enlargement (Paratcha et al. 2003), may be due to its ability to
keep NCAM-mediated cell adhesion in check among popula-
tion of migratory cells. By limiting NCAMcell adhesion func-
tions, GFRα1 may help to regulate cellular migration in many
sites of the developing nervous system. Such function may
also be ancient and evolutionary conserved. Drosophila
GDNF receptor-like (DmGfrl) encodes a GPI-anchored mem-
brane protein with similarities to GFRα1, and one study found
a genetic interaction between the gene encoding DmGfrl and
the Drosophila NCAM homolog FasII in the regulation of
fertility in the flies (Kallijärvi et al. 2012). The two proteins
were also found to associate biochemically (Kallijärvi et al.
2012), a result that is also reminiscent of the interaction be-
tween GFRα1 and mammalian NCAM. In the next section,
we describe other possible GFRα co-receptors and mecha-
nisms used by GDNF ligands independently of RET and
NCAM.
Other mechanisms of RET-independent signaling by
GDNF ligands
Although the preferred paradigm for RET-independent signal-
ing by GDNF ligands involves the presence of an alternative
transmembrane receptor, such as NCAM, early on researchers
had speculated with other mechanisms not requiring a trans-
membrane partner. These ideas emanated from the ability of
GFRα1 to couple to Src family kinases and the association
with both types of proteins with lipid rafts (Poteryaev et al.
1999; Trupp et al. 1999). A phenomenon termed monolayer
coupling had been described in sphingomyelin bilayer sys-
tems (Schmidt et al. 1978) which was later proposed as a
possible signaling mechanism for GPI-anchored receptors in-
volving coupling between rafts in the outer leaflet with rafts in
the inner leaflet (Brown and London 1998). It remains possi-
ble that Src family kinases might be concentrated and activat-
ed simply by partitioning into lipid rafts, without the need of
physically binding GFRα1 directly. Moving forward, it will
be important to carefully rule out the involvement of other
possible transmembrane molecules, not only RET, before
delving into alternative mechanisms to explain RET-
independent signaling. In this regard, for example, it has been
reported that GFRα1 is able to promote GDNF internalization
in fibroblasts independently of RET (Vieira et al. 2003), but
NCAM can be present in fibroblasts (Nakatani et al. 2006).
Likewise, the reported effects of GFRα1 independently of
RET on cisplatin-induced chemoresistance in osteosarcoma
(Kim et al. 2017) could also have involved NCAM present
in these cells (Ely and Knowles 2010).
A number of studies have described unexpected signaling
and biological activities of GDNF through GFRα1 indepen-
dently of either RET or NCAM in cortical GABAergic inter-
neurons and their precursors from the medial ganglionic em-
inence (MGE). The first set of studies used cultured MGE
cells and knock-out mice lacking either GFRα1, RET, or
NCAM to show that GDNF and GFRα1 promote differentia-
tion and tangential migration of cortical GABAergic neurons
independently of RET or NCAM (Pozas and Ibáñez 2005).
GDNF induced the GABAergic phenotype in cultured MGE
precursors and promoted their morphological differentiation.
In organotypic cultures, microbeads coated with GDNF could
induce the migration of GABAergic neurons in the cortex.
These effects were abolished in cultures derived from Gfra1
mutant mice, but not in those derived from either Ret or Ncam
mutants. In vivo, newborn knock-out mice lacking GDNF or
GFRα1 showed a marked reduction in cortical GABAergic
neurons, but no such losses could be detected in mice lacking
RET or NCAM (Pozas and Ibáñez 2005). As a way to circum-
vent the early lethality of Gfra1 null mutants, a second study
used the so-called cis-only mutant mice that lack GFRα1 only
in cells that do not express RET and which survive to adult-
hood (Enomoto et al. 2004). At birth, the cis-only mice
phenocopied the specific loss of GABAergic interneurons in
rostro- and caudolateral cortical regions previously seen in the
null mutants (Canty et al. 2009). Surprisingly, the adult cortex
of cis-only mice displayed a complete loss of parvalbumin-
expressing GABAergic interneurons in discrete regions inter-
spersed among areas of normal parvalbumin cell density.
Consistent with deficits in cortical inhibitory activity, cis-
only mice showed enhanced cortical excitability, increased
sensitivity to epileptic seizure, and abnormal social behavior
(Canty et al. 2009). As GFRα1 had been removed exclusively
from neurons that did not express RET, the effects of GFRα1
on these cells were per definition RET independent. Since
knock-out mice lacking NCAM did not show deficits in cor-
tical GABAergic neurons (Pozas and Ibáñez 2005), it was
speculated that GFRα1 contributed to the development of
these cells by partnering with an unknown transmembrane
receptor, or through alternative mechanisms, such as ligand-
induced cell adhesion. More generally, the results suggested a
role for GFRα1 in the allocation of parvalbumin interneurons
to specific cortical areas. Since the areas mostly affected,
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namely, caudal and frontal cortices, are the regions furthest
away from the birth place of these cells in the MGE, a general
decrease in neuronal migration could in principle explain the
specific deficits in those areas. Because mature GABAergic
neurons no longer express GFRα1 once in the cortex, GFRα1
may function by directing the differentiation and migration of
a distinct subpopulation of GABAergic precursors to specific
cortical areas. Searching for possible molecular mechanisms
of GFRα1 function in these cells, a later study employed
different in vitro systems to test the effects of soluble
GFRα1 presented exogenously in the differentiation and mi-
gration of MGE cells (Perrinjaquet et al. 2011). These studies
revealed that exogenous GFRα1 supplied in soluble form to
primary MGE cultures derived from mutant mice lacking
GFRα1 could rescue the effects of the mutation, a result that
is only compatible with the existence of a transmembrane
signaling partner for the GDNF-GFRα1 complex in
GABAergic neurons. In the same study, two candidate recep-
tors previously implicated in GABAergic neuron develop-
ment were tested, namely, the neuregulin receptor ErbB4
and the receptor for hepatocyte growth factor MET. The
MET receptor was also an intriguing GDNF receptor candi-
date, as a previous study had shown that GDNF could pro-
mote tubulogenesis of GFRα1-expressing kidney cells by in-
ducing Src-mediated phosphorylation and activation of MET
(Popsueva et al. 2003). However, GDNF did not induce the
activation of either ErbB4 or MET in GABAergic cells from
the MGE nor did inhibition of either receptor impair GDNF
activity in these cells (Perrinjaquet et al. 2011). Surprisingly,
MET inhibition or knock-out increased the expression of
GFRα1 in MGE cells and promoted their differentiation,
un cove r i n g an unexpe c t e d i n t e r p l a y b e tween
GDNF/GFRα1/MET signaling pathways in the early diversi-
fication of cortical GABAergic interneurons.
Asmentioned earlier, due to their highly positively charged
molecular surfaces, several members of the GDNF family
interact strongly with heparin-like molecules, including hepa-
ran sulfate (Ibáñez et al., unpublished and (Bespalov et al.
2011). Interestingly, heparan sulfate proteoglycans (HSPG),
such as members of the syndecan family, are transmembrane
molecules profusely decorated by heparin sulfate moieties,
and a study from the laboratory of Mart Saarma and col-
leagues showed that syndecan-3 in particular could bind
GDNF and other members of the family independently of
GFRα1 (Bespalov et al. 2011). Intriguingly, GDNF ligands
needed to be immobilized to extracellular substrates to effec-
tively bind to and induce cell spreading and neurite outgrowth
via syndecan-3, suggesting a clustering effect was involved. It
is also interesting to note that these researchers found that
deletion of the gene encoding syndecan-3 diminished the ef-
fects of GDNF on cell migration ofMGE-derived GABAergic
cells, although the effect of the mutation showed statistical
significance only at very high (100 μM) concentrations of
GDNF (Bespalov et al. 2011), way above the range used in
the studies discussed above, suggesting that a very high recep-
tor occupancy, such as that afforded by extracellular matrix
clustering, may be required for syndecan-3 to mediate GDNF
activities in those cells.
Finally, it should be mentioned that a few studies have
reported that members of the integrin family may also be
involved in GDNF signaling across the plasma membrane,
although in most cases, the participation of RET in the effects
observed was not tested and thus it remains unclear to which
extent integrins can meditate GDNF effects on their own. In
midbrain dopaminergic neurons, some of the effects of GDNF
on survival, neurite outgrowth, and signaling could be dimin-
ished by blocking antibodies against either integrin αv or
integrin β1 (Cao et al. 2008b; Chao et al. 2003). In the latter
study, GFRα1 could be immunoprecipitated together with
integrin β1 from tissue homogenates of the substantia nigra,
containing dopaminergic neurons, and this was increased in
brains that received injections of GDNF (Cao et al. 2008b),
although it was not reported whether comparable levels of
integrin β1 were immunoprecipitated under the different con-
ditions used in the experiments. Moreover, as dopaminergic
neurons also express RET and NCAM, the precise role played
by integrins in the effects observed remains unclear. Another
study investigated effects of GDNF on explants of midgut
extracted from wild-type and mice lacking integrin β1 and
found that GDNF could still induce outgrowth from the enter-
ic neurons lacking integrin β1 but could not function as a
chemoattractant, as the neurons remained within the explant,
in contrast to the wild-type explants (Breau et al. 2006).
Again, as these neurons express high levels of GFRα recep-
tors and RET, it is unclear whether integrin β1 can function
independently to mediate GDNF effects on cell migration.
Finally, it has also been reported that RET knock-down in
mouse sensory neurons abolished some, but not all, effects
of GDNF on those cells in vitro, particularly in the evoked
release of the neuropeptide calcitonin gene-related peptide
(CGRP) (Schmutzler et al. 2011). However, it was not inves-
tigated whether GFRα1 or NCAM were required. In summa-
ry, although integrin signaling may in some cases contribute
to the biological effects of GDNF ligands, requirement does
not mean sufficiency, and so it remains unclear whether
integrins can on their own mediate GDNF activities indepen-
dently of RET or other GDNF receptors.
Conclusions
As it is evident from the research described in this paper, RET-
independent signaling by GDNF ligands and GFRα receptors
contributes to a wide variety of important biological activities
and physiological processes (summarized in Table 1).
Research into these mechanisms has not only provided
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explanations for intriguing functions but also allowed the dis-
covery of previously unknown phenomena, such as ligand-
induced cell adhesion. From its initial discovery at the end
of the 1990’s, the field has moved on at increasing pace,
benefitting from a wealth of new tools and reagents, not the
least a wide range of lines of transgenic and targeted mice that
allowed teasing out the different molecular components con-
tributing to the functions of GDNF family ligands. We look
forward to several more decades of exciting discoveries.
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